![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/10/2910971/0/en/BiomX-Inc-Announces-Stockholder-Approval-for-Conversion-of-Outstanding-Series-X-Convertible-Preferred-Stock-to-Common-Stock.html
https://www.globenewswire.com/news-release/2024/05/30/2891178/0/en/BiomX-Inc-Receives-Notice-of-Non-Compliance-with-NYSE-American-Continued-Listing-Standards.html
https://www.globenewswire.com/news-release/2024/05/30/2890609/0/en/BiomX-to-Present-Phase-1b-2a-Clinical-Trial-Data-for-BX004-at-the-47th-European-Cystic-Fibrosis-Conference-and-at-ASM-Microbe-2024.html
https://www.globenewswire.com/news-release/2024/05/21/2885399/0/en/BiomX-Reports-First-Quarter-2024-Financial-Results-and-Provides-Business-and-Program-Updates.html
https://www.globenewswire.com/news-release/2024/04/18/2865310/0/en/BiomX-Announces-the-Appointment-of-Susan-Blum-to-its-Board-of-Directors.html
https://www.biospace.com/article/releases/biomx-announces-compliance-with-nyse-guidelines-on-audit-opinion-disclosure/
https://www.globenewswire.com/news-release/2024/04/03/2856746/0/en/BiomX-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/03/27/2852992/0/en/BiomX-to-Host-Fourth-Quarter-and-Full-Year-2023-Financial-Results-Conference-Call-and-Webcast-on-April-3rd-2024.html
https://www.globenewswire.com/news-release/2024/03/18/2847627/0/en/BiomX-Announces-Closing-of-the-Acquisition-of-Adaptive-Phage-Therapeutics-and-Concurrent-50-Million-Financing.html
https://www.globenewswire.com//news-release/2024/03/06/2841300/0/en/BiomX-Announces-Entry-into-Merger-Agreement-with-Adaptive-Phage-Therapeutics-and-Concurrent-50-Million-Financing.html